IntrinsicIntrinsic
← All summaries

Caesarstone Ltd.

CSTE
Financials & Chart →

Business Summary

Caesarstone Ltd. is a global multi-material designer, producer, and reseller of surfaces, primarily used as countertops in residential and commercial buildings . The global countertop industry generated approximately $151.6 billion in sales to end consumers in 2024, based on average installed price, which includes fabrication, installation, and other service-related costs . The company's products are sold in approximately 60 countries through a combination of direct sales and a network of independent distributors . Engineered stone countertops are a growing category, with global engineered quartz sales to end-consumers growing at a compound annual growth rate of 14.3% between 1999 and 2024, compared to a 5.2% compound annual growth rate in total global countertop sales . Porcelain sales to end-consumers grew at a compound annual growth rate of 30.5% between 2016 and 2024 .

The company faces intense competitive pressures from other surface materials and brands, competing on factors such as pricing, brand awareness, product quality, differentiation, design, breadth of offerings, and technological innovation . Competitors may produce or source similar products at lower costs, potentially reducing Caesarstone's market share and limiting its ability to increase prices . The engineered stone and porcelain surface market is highly fragmented, with growing competition from low-cost manufacturers from Asia and Europe, and large multinational companies investing in their production capabilities .

Caesarstone generates revenue from sales of surfaces, and to a lesser extent, their fabrication and installation services, and ancillaries . The majority of sales are to fabricators and resellers in direct markets and to third-party distributors in indirect markets . Direct sales accounted for 89% of revenues for the year ended December 31, 2025 . The company's business model includes providing fabrication and installation services in certain market channels in the U.S., Canada, Israel, and Australia, which are sourced from third-party fabricators .

The company's products are generally marketed under the Caesarstone brand and Lioli brand, with products sold through IKEA marketed as LOCKEBO and KASKER . Engineered stone products are comprised of an average of 85% minerals blended with polyester and pigments . Porcelain products are comprised of clay minerals, natural minerals, and additives . The product offerings include collections such as Classico, Supernatural, Metropolitan, Outdoor, and Porcelain . In 2024, Caesarstone began transitioning its portfolio to crystalline silica-free surfaces (CSF), which may contain traces of crystalline silica of up to 1%, made from approximately 80% recycled materials . Additionally, following the Omicron acquisition, the company offers resale of natural stone, sinks, and various ancillary fabrication tools and materials in the United States .

In 2025, products produced by third parties accounted for approximately 51% of revenues . The company's engineered stone products are now manufactured by third-party Production Business Partners (PBPs) located in the Far East, India, the Middle East, and Europe, following the closure of its own engineered stone production facilities . Porcelain products are manufactured at the in-house facility in Morbi, Gujarat, India, and by third-party PBP partners . In 2025, approximately 73% of total engineered stone sourcing was manufactured by PBPs, with this trend expected to significantly increase in 2026 to include all engineered stone products . Approximately 49% of PBP-manufactured products (or 36% of total engineered stone products) were sourced from "Supplier A," and approximately 31% (or 23% of total engineered stone products) from "Supplier B" .

For the fiscal year ended December 31, 2025, Caesarstone reported total revenue of $397.2 million . Gross profit was $73.280 million , resulting in a gross margin of 18.4% . Operating loss for the period was $125.709 million , representing an operating margin of -31.6% . Net loss was $137.759 million , and net loss attributable to controlling interest was $137.467 million , with a margin of -34.6% . Diluted EPS is not explicitly provided in the summary financial data. Adjusted EBITDA was a loss of $32.560 million , with an adjusted EBITDA margin of -8.2% . Adjusted net loss attributable to controlling interest was $51.925 million , with a margin of -13.1% . Capital expenditures for 2025 amounted to $9.0 million . As of December 31, 2025, the company had outstanding bank credit of $2.4 million , all payable within 12 months . Cash and cash equivalents are not explicitly stated in the summary.

Revenue decreased by $46.0 million, or 10.4%, to $397.2 million in 2025 from $443.2 million in 2024 . On a constant currency basis, 2025 revenue was lower by 10.5% year-over-year . Gross margin decreased to 18.4% in 2025 from 21.8% in 2024 . The adjusted gross margin decreased from 22.1% in 2024 to 19.0% in 2025 . The adjusted EBITDA margin decreased from a negative 2.6% in 2024 to a negative 8.2% in 2025 . The margin of adjusted net loss attributable to controlling interest increased from an adjusted net loss of 6.7% in 2024 to an adjusted net loss of 13.1% in 2025 . Research and development expenses increased by $0.7 million or 14.6%, reaching $5.7 million in 2025, compared to $4.9 million in 2024 . Selling and marketing expenses decreased by $6.7 million, or 7.8%, to $79.5 million in 2025, compared to $86.2 million in 2024 . General and administrative expenses increased by $0.4 million, or 0.9%, to $39.5 million in 2025 from $39.1 million in 2024 . Legal settlements and loss contingencies, net, increased by $18.4 million, from $7.2 million expenses in 2024 to $25.6 million in 2025 .

During 2025, the company completed the acquisition of the remaining minority equity interests in Lioli Ceramica Pvt. Ltd. for approximately $1.9 million, resulting in 100% ownership of Lioli as of December 31, 2025 . The manufacturing network underwent restructuring, shifting focus from in-house production, with operations discontinued at Sdot-Yam, Israel, Bar-Lev, Israel, and Richmond Hill, GA, USA facilities . Impairment charges of approximately $45.7 million were recorded in 2025, primarily related to the Bar Lev facility, the held-for-sale Richmond Hill facility, and the right-of-use asset at the Bar Lev facility . Restructuring expenses related to manufacturing facility closures and partial asset sales totaled approximately $3.1 million in 2025 .

Business Outlook

A key element of Caesarstone's strategy is to expand sales in certain existing markets, such as the United States, and additional new markets and offerings with high growth potential . The company is optimizing its distribution network in the United States, including through the expansion of its brand into the South, Southeast, and Ohio Valley markets via the Omicron Acquisition . A growing portion of revenues is attributable to installation and fabrication services . The company estimates it can continue to expand its brand and product sales in the United States, where engineered surfaces represented 4.9% of total countertops by volume installed in 2024 .

The company's R&D efforts are focused on the development of innovative CSF products, currently primarily tailored for the Australian market . Additionally, the R&D department has expanded its focus to include the development of porcelain products for various global markets and diverse applications, working in close collaboration with the manufacturing facility in Lioli, India . The company aims to increase purchases from PBPs in 2026 .

Caesarstone attributes the decrease in adjusted EBITDA margin in 2025 mainly to lower sales, including lower average selling prices, increased manufacturing costs per unit due to lower capacity utilization in the Bar Lev plant, resulting in lower fixed-costs absorption, higher logistics costs, and increased tariffs to the U.S. market . These impacts were partially offset by savings from an increased portion of PBP-produced product sales and operating expenses savings . The company is implementing a digital transformation to better streamline processes and support its business strategy, with technological and digital investments geared towards operational enhancements in supply chain management and production, along with improvement of go-to-market tools .

The company's primary capital requirements have been to fund production capacity expansions, investments in and acquisitions of third-party distributors, and the establishment of German operations . Other capital requirements include funding working capital needs, legal proceedings, operating costs, debt payments, share repurchases, and dividends . Capital expenditures for 2025 were $9.0 million . The company's inventory strategy is to maintain sufficient inventory levels to meet anticipated customer demand, with inventory significantly impacted by sales in the United States, Australia, and Canada due to the 20-100 days required to ship products from PBP sources . The company believes that, based on its current business plan, its cash, cash equivalents, short-term bank deposits, and cash from operations will be sufficient to meet capital expenditure, working capital, and liquidity needs for at least the next twelve months .

The company's capital needs could increase materially, and liquidity and cash flows could be materially affected by the uncertainty related to bodily injury claims . The company is subject to multiple lawsuits alleging injuries associated with exposure to respirable crystalline silica dust . As of December 31, 2025, a provision of $47.2 million was recorded for probable and estimable exposure with respect to pending claims . If there is an unfavorable outcome, subject to insurance availability, the payment of damages could be significant and materially and adversely impact cash flows . The company has lease payment obligations of $133.3 million as of December 31, 2025, with $29.9 million payable within 12 months . Purchase obligations for products and raw materials amounted to $15.9 million as of December 31, 2025, all payable within 12 months . The company had outstanding bank credit of $2.4 million as of December 31, 2025, all payable within 12 months, with future interest payments totaling $0.2 million, also payable within 12 months .

Risk Factors

Caesarstone faces several material risks, including adverse outcomes and potential losses from bodily injury claims related to respirable crystalline silica exposure, with 618 injured persons globally as of December 31, 2025 , and a provision of $47.3 million recorded for probable and estimable exposure . The company is unable to obtain insurance coverage for future silicosis claims, and existing coverage is disputed by insurers, potentially leading to insufficient coverage . Global trade is affected by governmental involvement, including antidumping and countervailing duties, which can cause unforeseeable market changes and increase costs, such as the 3.18% subsidy rate assigned to porcelain products imported from India . Changes in laws and regulations relating to hazards associated with engineered stone surfaces, such as the ban on engineered stone slabs containing crystalline silica in most Australian states and territories effective July 1, 2024 , may adversely affect the business. Economic downturns, particularly in home renovation and construction, high inflation, and increased interest rates, may lower demand for products . The company relies on a network of third-party Production Business Partners (PBPs), with approximately 24% of products manufactured at more than one PBP facility , and disruptions or failures in managing these relationships could adversely affect competitive position, results, or profitability. Fluctuations in currency exchange rates, particularly the Australian dollar, Canadian dollar, NIS, and Euro against the U.S. dollar, may materially and adversely affect profitability . The inability to offset or pass on increases in costs or adverse changes in global sourcing, manufacturing, and supply conditions could materially adversely affect financial results . The company may need to raise funds to finance capital needs, which could dilute shares, increase financial expenses, or limit business activities . Disruptions to or failure to upgrade IT systems globally may impair operations and hinder growth . The steps taken to protect brand, technology, and intellectual property may be inadequate, and the company may not succeed in preventing others from appropriating its intellectual property . Compliance with continuously evolving privacy and data protection laws and regulations, such as the California Consumer Privacy Act (CCPA) and the General Data Protection Regulation (GDPR), may result in significant liability . The company may have exposure to greater-than-anticipated tax liabilities, including challenges to transfer pricing arrangements and the allocation of income related to production outside of Israel . Environmental, health, and safety regulations, such as those in India, may be costly or difficult to comply with, potentially leading to civil and criminal sanctions . Litigation, disputes, or other proceedings, including a putative class action lawsuit seeking medical monitoring for workers exposed to artificial stone dust in California , could result in unexpected expenses. Failure to meet ESG expectations or standards could adversely affect the business . Operating results may suffer due to failure to manage international operations effectively or regulatory changes in foreign jurisdictions . Conditions in Israel and regional instability may adversely affect operations, including the call-up of employees for military reserve duty . The tax benefits available to the Israeli facilities, such as the "Preferred Enterprise" status, require meeting various conditions and may be terminated or reduced in the future . The substantial share ownership position of Kibbutz Sdot-Yam and Tene, which together beneficially owned 40.6% of outstanding shares as of February 27, 2026 , limits the ability of other shareholders to influence corporate matters.

Management Priorities

Management's message to shareholders emphasizes the company's mission to be the leading choice for surfaces globally, with a significant portion of future growth expected from the U.S. market, which is seen as having the greatest growth opportunity . The company believes that long-term competitiveness requires both organic growth and strategic acquisitions . Management has successfully executed on this strategy in recent years, including the 2020 acquisitions of Lioli and Omicron, and the 2022 acquisition of Caesarstone Scandinavia . The company is actively working to optimize its global production footprint by shifting from in-house production to sourcing engineered stone products from third-party Production Business Partners (PBPs) . In 2025, the company completed the acquisition of the remaining minority interests in Lioli for approximately $1.9 million, achieving 100% ownership . Management is also focused on developing innovative crystalline silica-free (CSF) products, particularly for the Australian market, and expanding its porcelain product offerings globally . The company is implementing a digital transformation to streamline processes, enhance supply chain management, and improve go-to-market tools . Despite a revenue decrease of 10.4% in 2025 to $397.2 million , management is implementing cost-saving measures as part of its strategic restructuring plan, which contributed to a decrease in selling and marketing expenses by 7.8% .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 4.B, Business Overview
  2. [2] Item 4.B, Business Overview
  3. [3] Item 4.A, History and Development of the Company
  4. [4] Item 4.B, Business Overview
  5. [5] Item 4.B, Business Overview
  6. [6] Item 4.B, Competition
  7. [7] Item 3.D, Risk Factors — We face intense competitive pressures which could materially and adversely affect our results of operations and financial condition
  8. [8] Item 4.B, Competition
  9. [9] Item 5.A, Operating Results — Components of statements of income
  10. [10] Item 5.A, Operating Results — Components of statements of income
  11. [11] Item 5.A, Operating Results — Components of statements of income
  12. [12] Item 4.B, Distribution
  13. [13] Item 4.B, Our Products
  14. [14] Item 4.B, Our Products
  15. [15] Item 4.B, Our Products
  16. [16] Item 4.B, Our Products
  17. [17] Item 4.B, Our Products
  18. [18] Item 4.B, Our Products
  19. [19] Item 4.B, Manufacturing and Facilities
  20. [20] Item 4.B, Manufacturing and Facilities
  21. [21] Item 4.B, Manufacturing and Facilities
  22. [22] Item 4.B, Production Business Partners Relationships
  23. [23] Item 4.B, Production Business Partners Relationships
  24. [24] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  25. [25] Item 4.B, Non-GAAP Financial Measures
  26. [26] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  27. [27] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  28. [28] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  29. [29] Item 4.B, Non-GAAP Financial Measures
  30. [30] Item 4.B, Non-GAAP Financial Measures
  31. [31] Item 5.A, Operating Results — Company overview
  32. [32] Item 4.B, Non-GAAP Financial Measures
  33. [33] Item 5.A, Operating Results — Company overview
  34. [34] Item 4.B, Non-GAAP Financial Measures
  35. [35] Item 5.A, Operating Results — Company overview
  36. [36] Item 4.A, Principal Capital Expenditures
  37. [37] Item 5.B, Liquidity and Capital Resources — Debt
  38. [38] Item 5.B, Liquidity and Capital Resources — Debt
  39. [39] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  40. [40] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  41. [41] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  42. [42] Item 5.A, Operating Results — Company overview
  43. [43] Item 5.A, Operating Results — Company overview
  44. [44] Item 5.A, Operating Results — Company overview
  45. [45] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  46. [46] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  47. [47] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  48. [48] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  49. [49] Item 5.A, Operating Results — Acquisitions
  50. [50] Item 4.A, History and Development of the Company
  51. [51] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  52. [52] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  53. [53] Item 3.D, Risk Factors — A key element of our strategy is to expand our sales in certain markets, such as the United States and segments, such as services. Failure to expand such sales would have a material adverse effect on our future growth and prospects
  54. [54] Item 3.D, Risk Factors — A key element of our strategy is to expand our sales in certain markets, such as the United States and segments, such as services. Failure to expand such sales would have a material adverse effect on our future growth and prospects
  55. [55] Item 3.D, Risk Factors — A key element of our strategy is to expand our sales in certain markets, such as the United States and segments, such as services. Failure to expand such sales would have a material adverse effect on our future growth and prospects
  56. [56] Item 3.D, Risk Factors — A key element of our strategy is to expand our sales in certain markets, such as the United States and segments, such as services. Failure to expand such sales would have a material adverse effect on our future growth and prospects
  57. [57] Item 4.B, Research and Development
  58. [58] Item 4.B, Research and Development
  59. [59] Item 4.B, Manufacturing and Facilities
  60. [60] Item 5.A, Operating Results — Company overview
  61. [61] Item 5.A, Operating Results — Company overview
  62. [62] Item 4.B, Information Technology Systems
  63. [63] Item 5.B, Liquidity and Capital Resources
  64. [64] Item 5.B, Liquidity and Capital Resources
  65. [65] Item 5.B, Liquidity and Capital Resources — Capital expenditures
  66. [66] Item 5.B, Liquidity and Capital Resources
  67. [67] Item 5.B, Liquidity and Capital Resources
  68. [68] Item 5.B, Liquidity and Capital Resources
  69. [69] Item 5.B, Liquidity and Capital Resources
  70. [70] Item 5.B, Liquidity and Capital Resources
  71. [71] Item 5.B, Liquidity and Capital Resources
  72. [72] Item 5.B, Liquidity and Capital Resources — Leases
  73. [73] Item 5.B, Liquidity and Capital Resources — Purchase Obligations
  74. [74] Item 5.B, Liquidity and Capital Resources — Debt
  75. [75] Item 3.D, Risk Factors — Adverse outcomes and potential losses from bodily injury claims may have a material adverse effect on our business, operating results, financial condition and cash flows
  76. [76] Item 8.A, Legal Proceedings — Our Probable Risks Related to Outstanding Claims
  77. [77] Item 3.D, Risk Factors — We are unable to obtain insurance coverage for future claims relating to silicosis, our entitlement to receive coverage based on existing policies is being disputed by insurers, and our coverage will be insufficient if our position is not accepted by courts and juries
  78. [78] Item 3.D, Risk Factors — Global trade is affected by governmental involvement, including through antidumping and countervailing duties and these may cause unforeseeable market changes that could adversely impact our financial results
  79. [79] Item 3.D, Risk Factors — Changes in laws and regulations relating to hazards associated with engineered stone surfaces or with the crystalline silica in stone surfaces may adversely and materially affect our business
  80. [80] Item 3.D, Risk Factors — Economic downturns, particularly in home renovation and construction may materially and adversely impact end-consumers and lower demand for our products, which may cause our revenues and net income to decrease
  81. [81] Item 3.D, Risk Factors — Our reliance on our network of third-party Production Business Partners (PBP), including concentration risks relating to certain products, technologies or geographic regions, could materially adversely affect our competitive position, results of operations or profitability
  82. [82] Item 3.D, Risk Factors — Our results of operations may be materially and adversely affected by fluctuations in currency exchange rates, and we may not have adequately hedged against them
  83. [83] Item 3.D, Risk Factors — If we are unable to offset or pass on increases in costs or adverse changes in global sourcing, manufacturing and supply conditions, our business, financial condition and results of operations could be materially adversely affected
  84. [84] Item 3.D, Risk Factors — We may need to raise funds to finance our current and future capital needs, which may dilute the value of our outstanding ordinary shares, increase our financial expenses or limit our business activities
  85. [85] Item 3.D, Risk Factors — Disruptions to or our failure to upgrade and adjust our information technology systems globally may materially impair our operations, hinder our growth, and materially and adversely affect our business and results of operations
  86. [86] Item 3.D, Risk Factors — The steps that we have taken to protect our brand, technology and other intellectual property may not be adequate, and we may not succeed in preventing others from appropriating our intellectual property
  87. [87] Item 3.D, Risk Factors — Compliance with continuously evolving privacy and data protection laws and regulations, and any actual or perceived failure to comply with such laws and regulations may result in significant liability, negative publicity, and/or erosion of trust and could have an adverse effect on our revenues, results of operations and financial condition
  88. [88] Item 3.D, Risk Factors — We may have exposure to greater-than-anticipated tax liabilities
  89. [89] Item 3.D, Risk Factors — Environmental, health and safety regulations, industry standards and other similar matters may be costly, difficult or impossible to comply with under our existing operations and could negatively impact our financial condition and results of operations
  90. [90] Item 8.A, Legal Proceedings — United States
  91. [91] Item 3.D, Risk Factors — Failure to meet ESG expectations or standards or a failure to effectively pursue our ESG goals could adversely affect our business, results of operations, financial condition, or stock price
  92. [92] Item 3.D, Risk Factors — Our operating results may suffer due to our failure to manage our international operations effectively or due to regulatory changes in the jurisdictions where we operate
  93. [93] Item 3.D, Risk Factors — Conditions in Israel and regional instability may adversely affect our operations
  94. [94] Item 3.D, Risk Factors — The tax benefits that are available to us require us to continue to meet various conditions and may be terminated or reduced in the future, which could increase our costs and taxes
  95. [95] Item 7.A, Major Shareholders
  96. [96] Item 5.A, Operating Results — Company overview
  97. [97] Item 5.A, Operating Results — Company overview
  98. [98] Item 5.A, Operating Results — Company overview
  99. [99] Item 5.A, Operating Results — Cost of revenues and gross profit margin
  100. [100] Item 5.A, Operating Results — Acquisitions
  101. [101] Item 4.B, Research and Development
  102. [102] Item 4.B, Information Technology Systems
  103. [103] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024
  104. [104] Item 5.A, Operating Results — Comparison of period-to-period results of operations — Year ended December 31, 2025, compared to year ended December 31, 2024

Analysis on 5/22/2026